{
    "clinical_study": {
        "@rank": "55394", 
        "brief_summary": {
            "textblock": "This study is being done to evaluate the use of MRI during radiation treatment planning to\n      identify areas of tumor within the prostate to aid in future treatment planning and\n      targeting of prostate cancer. This study will be conducted at the University of Pennsylvania\n      Health System. The study is projected to run for 18 months. Subjects will be male 18 or\n      older with a prostate cancer diagnosis and treatment plansat the Department of Radiation\n      Oncology."
        }, 
        "brief_title": "Functional MRI Use in Prostate Radiation Treatment Planning", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 or older\n\n          -  Male\n\n          -  Biopsy proven prostate cancer without evidence of metastatic disease\n\n          -  Planned definitive external beam RT with daily ERB and implanted Visicoil fiducial\n             markers.\n\n          -  Prior fMRI-ec documenting an IPL 25 mm2 in axial bidimensional diameter product,\n             concordant with intraprostatic tumor location as documented on transrectal\n             ultrasoundbiopsy\n\n          -  Subject capable of giving informed consent for standard external beam RT and for the\n             study.\n\n          -  No current contraindication that would prevent MRI or gadolinium contrast.\n\n        Exclusion Criteria:\n\n          -  Metastatic disease\n\n          -  Lack of fMRI-ec documeneting an IPL 25 mm2 in axial bidimensional product, concordant\n             with intraprostatic tumor location as documented on transrectal untrasound biopsy\n\n          -  Neoadjuvant androgen deprivation therapy greater than 10 weeks, defined from date of\n             LHRH analog injection to date of fMRI-sim\n\n          -  Contraindication that would prevent MRI or gadolinium contrast\n\n          -  GFR 30 mL/min/1.73m2 per Crockoft-Gault formula."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985932", 
            "org_study_id": "UPCC 07812"
        }, 
        "intervention": {
            "intervention_name": "MRI", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "Abramson Cancer Center of the University of Pennsylvania"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Prospective Study Evaluating Non-Endorectal Coil Functional MRI Identification of Intraprostatic Tumor During Radiation Treatment Planning", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985932"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Abramson Cancer Center of the University of Pennsylvania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abramson Cancer Center of the University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}